Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
After-Hours
In 70 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Definium Therapeutic
Definium Therapeutics, formerly MindMed, is a US clinical-stage biopharmaceutical company. It develops treatments for brain-health disorders such as generalized anxiety disorder and major depression, led by its lead candidate DT120.
Frequently asked questions
When will Definium Therapeutic report its next quarterly earnings?
Definium Therapeutic is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Definium Therapeutic last report quarterly earnings?
Definium Therapeutic last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -1.44 USD.
How often has Definium Therapeutic beaten expectations?
Definium Therapeutic has beaten analyst EPS estimates in 0 of its last 5 evaluated quarters (beat rate: 0%).
How do I add the Definium Therapeutic earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
0/5
Quarters above estimates
0%
Beat rate
-43.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Definium Therapeutic
Country
🇺🇸
More Financial Information